Next Article in Journal
Novel Cinnamic Acid Derivatives as Antioxidant and Anticancer Agents: Design, Synthesis and Modeling Studies
Next Article in Special Issue
Towards the Development of Functionalized PolypyridineLigands for Ru(II) Complexes as Photosensitizers inDye-Sensitized Solar Cells (DSSCs)
Previous Article in Journal
Cytotoxic and Antiproliferative Effect of Tepary Bean Lectins on C33-A, MCF-7, SKNSH, and SW480 Cell Lines
Previous Article in Special Issue
An Unusual Conversion of Paramagnetic [3-Cl-3,3,8-{Ph2P(CH2)nPPh-µ-(C6H4-ortho)}-1,2-(CH3)2-closo-3,1,2-RuIIIC2B9H8] (n = 3 and 4) to Form the First 18-Electron P-Phenylene ortho-Cycloboronated closo-Ruthenacarboranes with a Dioxygen Ligand
Article Menu

Export Article

Open AccessReview
Molecules 2014, 19(7), 9628-9654; doi:10.3390/molecules19079628

Ruthenium Complexes as NO Donors for Vascular Relaxation Induction

1
Faculdade de Ciências Integradas do Pontal, Universidade Federal de Uberlândia, Ituiutaba 38304-402, MG, Brazil
2
Departamento de Física e Química, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto 14040-903, SP, Brazil
*
Author to whom correspondence should be addressed.
Received: 8 April 2014 / Revised: 9 June 2014 / Accepted: 26 June 2014 / Published: 7 July 2014
(This article belongs to the Special Issue Ruthenium Complex)
View Full-Text   |   Download PDF [1534 KB, uploaded 7 July 2014]   |  

Abstract

Nitric oxide (NO) donors are substances that can release NO. Vascular relaxation induction is among the several functions of NO, and the administration of NO donors is a pharmacological alternative to treat hypertension. This review will focus on the physicochemical description of ruthenium-derived NO donor complexes that release NO via reduction and light stimulation. In particular, we will discuss the complexes synthesized by our research group over the last ten years, and we will focus on the vasodilation and arterial pressure control elicited by these complexes. Soluble guanylyl cyclase (sGC) and potassium channels are the main targets of the NO species released from the inorganic compounds. We will consider the importance of the chemical structure of the ruthenium complexes and their vascular effects. View Full-Text
Keywords: nitric oxide; ruthenium-derived complexes; vasodilation; blood pressure control; soluble guanylyl cyclase; potassium channels nitric oxide; ruthenium-derived complexes; vasodilation; blood pressure control; soluble guanylyl cyclase; potassium channels
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

de Lima, R.G.; Silva, B.R.; da Silva, R.S.; Bendhack, L.M. Ruthenium Complexes as NO Donors for Vascular Relaxation Induction. Molecules 2014, 19, 9628-9654.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top